Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.
Aberrant expression of microRNA-34a (miR-34a) has been reported to be involved in the tumorigenesis and progression of various classes of malignancies. However, its role in hepatocellular carcinoma (HCC) has not been completely clarified. In the current study, we have investigated the clinical signi...
Main Authors: | Yiwu Dang, Dianzhong Luo, Minhua Rong, Gang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3622605?pdf=render |
Similar Items
-
Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis <it>in vitro</it>
by: Rong Minhua, et al.
Published: (2013-01-01) -
Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
by: Minhua Rong, et al.
Published: (2020-03-01) -
Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells
by: Suning Huang, et al.
Published: (2014-01-01) -
Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
by: Suning Huang, et al.
Published: (2020-01-01) -
miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma
by: Gang Wu, et al.
Published: (2018-01-01)